U.S. Markets open in 1 hr 47 mins

Examining Amgen’s Revenue Trend in Q2 2018

Mike Benson
Examining Amgen’s Revenue Trend in Q2 2018

As we discussed earlier, Amgen (AMGN) reported a 4% rise in its year-over-year revenue to ~$6.06 billion in the second quarter compared to $5.81 billion in the first quarter of 2017. Amgen surpassed analysts’ estimates for EPS and revenue in the second quarter, reporting non-GAAP (generally accepted accounting principles) EPS of $3.83 on revenue of ~$6.1 billion compared to the estimate of $3.54 on revenue of $5.7 billion.